Spain In-vitro Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Spain In-vitro Diagnostics Market has been segmented by Technique, Product, Usability (Disposable IVD Devices and Reusable IVD Devices), Application, End User, and Geography

Market Snapshot

CAGR
Study Period:

2018 - 2026

Base Year:

2020

CAGR:

5.3 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The key factors propelling the growth of the Spanish in-vitro diagnostics market is the high prevalence of chronic diseases, increasing use of point-of-care (POC) diagnostics, and advanced technologies.

  • The increasing burden of chronic and infectious diseases and the rapidly evolving healthcare environment are expected to drive the in-vitro diagnostics market in Spain. They account for the majority of hospital admissions and prescriptions filling. They are also a major reason for physician visits. These diseases account for the vast majority of healthcare spending. Hence, the high prevalence of chronic diseases in the country is the primary factor responsible for the growth of the IVD market in Spain.
  • Owing to the ease of use and ability to provide instant results, combined with ease of procurement, the use of POC diagnostics in Spain is increasing rapidly, and this, in turn, is promoting the growth of the IVD market in the country. POC technologies form an influential driver for the market. In addition, rapid advancements in technology and increasing adoption toward novel technologies are the other factors contributing to the growth of the IVD market in the country.

Scope of the Report

As per the scope of the report, in-vitro diagnostics involves the medical devices and consumables that are utilized to perform in-vitro tests on various biological samples. These tests are done on samples, such as blood or tissue that have been taken from the human body. In-vitro diagnostics can detect diseases or other conditions and can be used to monitor a person's overall health to cure, treat, or prevent diseases.

By Test Type
Clinical Chemistry
Molecular Diagnostics
Hematology
Immuno Diagnostics
Other Types
By Product
Instrument
Reagent
Other Products
By Usability
Disposable IVD Devices
Reusable IVD Devices
By Application
Infectious Disease
Diabetes
Cancer/Oncology
Cardiology
Nephrology
Autoimmune Diseases
Other Applications
By End Users
Diagnostic Laboratories
Hospitals and Clinics
Other End Users

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Molecular Diagnostics Segment is Expected to Grow at Good Rate Over the Forecast Period

Molecular diagnostic devices are used to analyze biological markers in the genome and proteome to detect pathogens or mutations. On the basis of technology used, molecular diagnostic devices can be segmented into chips and microarrays, mass spectroscopy, next-generation sequencing (NGS), polymerase chain reaction (PCR)-based methods, cytogenetics, and molecular imaging. Factors, such as large outbreaks of bacterial and viral epidemics, increasing diseased population, and rapidly evolving technology in molecular diagnostics, are driving the growth. For instance, the outbreak of coronavirus, which has become a pandemic in a short period of time, has demanded high pressure of positive results from molecular diagnostics companies and laboratories, which is boosting the segment.

spain

To understand key trends, Download Sample Report

Competitive Landscape

The companies are found focusing on increasing technological advancements in order to address customer needs, like fully automated systems that save manual processes and consumables. Manual processes also provide fast and accurate results. In addition, all the major IVD companies have launched new products for strengthening their diagnostic capabilities.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 High Burden of Chronic and Infectious Diseases

      2. 4.2.2 Increasing Use of Point-of-care (POC) Diagnostics

      3. 4.2.3 Growing Demand for Rapid Tests and Advanced Technologies in Healthcare Facilities

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulations

      2. 4.3.2 Irregular Reimbursement Policies

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Test Type

      1. 5.1.1 Clinical Chemistry

      2. 5.1.2 Molecular Diagnostics

      3. 5.1.3 Hematology

      4. 5.1.4 Immuno Diagnostics

      5. 5.1.5 Other Types

    2. 5.2 By Product

      1. 5.2.1 Instrument

      2. 5.2.2 Reagent

      3. 5.2.3 Other Products

    3. 5.3 By Usability

      1. 5.3.1 Disposable IVD Devices

      2. 5.3.2 Reusable IVD Devices

    4. 5.4 By Application

      1. 5.4.1 Infectious Disease

      2. 5.4.2 Diabetes

      3. 5.4.3 Cancer/Oncology

      4. 5.4.4 Cardiology

      5. 5.4.5 Nephrology

      6. 5.4.6 Autoimmune Diseases

      7. 5.4.7 Other Applications

    5. 5.5 By End Users

      1. 5.5.1 Diagnostic Laboratories

      2. 5.5.2 Hospitals and Clinics

      3. 5.5.3 Other End Users

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 bioMerieux SA

      2. 6.1.2 Danaher Corporation

      3. 6.1.3 F. Hoffmann-La Roche AG

      4. 6.1.4 Becton, Dickinson and Company

      5. 6.1.5 Bio-Rad Laboratories Inc.

      6. 6.1.6 Abbott Laboratories

      7. 6.1.7 Arkray Inc.

      8. 6.1.8 Sysmex Corporation

      9. 6.1.9 Ortho Clinical Diagnostics

      10. 6.1.10 Siemens Healthcare GmbH

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Spain In-vitro Diagnostics Market market is studied from 2018 - 2026.

The Spain In-vitro Diagnostics Market is growing at a CAGR of 5.3% over the next 5 years.

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Biomeriux SA

Are the major companies operating in Spain In-vitro Diagnostics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!